Advanced Proteome Valuation
| APTCF Stock | USD 0.0002 0.00 0.00% |
Advanced Proteome seems to be overvalued based on Macroaxis valuation methodology. Our model approximates the value of Advanced Proteome from analyzing the firm fundamentals such as Shares Outstanding of 41.13 M, return on asset of -1.07, and Price To Earning of 2.98 X as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Advanced Proteome's price fluctuation is very steady at this time. Calculation of the real value of Advanced Proteome is based on 3 months time horizon. Increasing Advanced Proteome's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Advanced pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Advanced Proteome Therapeutics. Since Advanced Proteome is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Advanced Pink Sheet. However, Advanced Proteome's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.0E-4 | Real 1.68E-4 | Hype 2.0E-4 | Naive 2.0E-4 |
The real value of Advanced Pink Sheet, also known as its intrinsic value, is the underlying worth of Advanced Proteome Company, which is reflected in its stock price. It is based on Advanced Proteome's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Advanced Proteome's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Advanced Proteome Therapeutics helps investors to forecast how Advanced pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Advanced Proteome more accurately as focusing exclusively on Advanced Proteome's fundamentals will not take into account other important factors: Advanced Proteome Total Value Analysis
Advanced Proteome Therapeutics is presently forecasted to have takeover price of 660.53 K with market capitalization of 2.47 M, debt of 227.41 K, and cash on hands of 761.6 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Advanced Proteome fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
660.53 K | 2.47 M | 227.41 K | 761.6 K |
Advanced Proteome Asset Utilization
One of the ways to look at asset utilization of Advanced is to check how much profit was generated for every dollar of assets it reports. Advanced Proteome Therapeutics shows a negative utilization of assets of -1.07 percent, losing $0.0107 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Advanced Proteome Therapeutics shows how discouraging it operates for each dollar spent on its assets.Advanced Proteome Ownership Allocation
Advanced Proteome holds a total of 41.13 Million outstanding shares. Advanced Proteome Therapeutics shows 10.53 percent of its outstanding shares held by insiders and 0.0 percent owned by other corporate entities. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Advanced Proteome Profitability Analysis
Net Income was 759.62 K with loss before overhead, payroll, taxes, and interest of (1.71 K).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Advanced Proteome's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Advanced Proteome and how it compares across the competition.
About Advanced Proteome Valuation
The pink sheet valuation mechanism determines Advanced Proteome's current worth on a weekly basis. Our valuation model uses a comparative analysis of Advanced Proteome. We calculate exposure to Advanced Proteome's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Advanced Proteome's related companies.Advanced Proteome Therapeutics Corporation, through its subsidiary, Advanced Proteome Therapeutics Inc., operates as a biotechnology company in the United States. Its platform is dedicated to applications in the field of antibody drug conjugates, as well as focused on protein conjugates and immunomodulation. Advanced Proteome operates under Biotechnology classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Advanced Proteome's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Advanced Proteome's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Advanced Proteome's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Advanced Proteome's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Advanced Proteome's revenue streams: Identify Advanced Proteome's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Advanced Proteome's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Advanced Proteome's growth potential: Evaluate Advanced Proteome's management, business model, and growth potential.
- Determine Advanced Proteome's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Advanced Proteome's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Advanced Proteome Growth Indicators
Investing in growth stocks can be very risky. If the company such as Advanced Proteome does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 39.7 M | |
| Quarterly Earnings Growth Y O Y | 15.91 | |
| Retained Earnings | -22.3 M |
Complementary Tools for Advanced Pink Sheet analysis
When running Advanced Proteome's price analysis, check to measure Advanced Proteome's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Advanced Proteome is operating at the current time. Most of Advanced Proteome's value examination focuses on studying past and present price action to predict the probability of Advanced Proteome's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Advanced Proteome's price. Additionally, you may evaluate how the addition of Advanced Proteome to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |